MARKET

ABEO

ABEO

Abeona Therapeut
NASDAQ
5.71
+0.11
+1.96%
Opening 10:01 05/13 EDT
OPEN
5.58
PREV CLOSE
5.60
HIGH
5.75
LOW
5.47
VOLUME
231.15K
TURNOVER
--
52 WEEK HIGH
7.32
52 WEEK LOW
3.933
MARKET CAP
278.65M
P/E (TTM)
-3.6775
1D
5D
1M
3M
1Y
5Y
1D
Abeona Therapeutics Sells Priority Review Voucher for $155M
TipRanks · 1d ago
Abeona Therapeutics enters agreement to sell PRV for $155M
TipRanks · 1d ago
ABEONA THERAPEUTICS INC: ANTICIPATE BECOMING PROFITABLE IN EARLY 2026
Reuters · 1d ago
Weekly Report: what happened at ABEO last week (0505-0509)?
Weekly Report · 1d ago
Abeona Therapeutics® Enters into Agreement to Sell Priority Review Voucher for $155 Million
Barchart · 1d ago
Press Release: Abeona Therapeutics(R) Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dow Jones · 5d ago
Weekly Report: what happened at ABEO last week (0428-0502)?
Weekly Report · 05/05 11:15
Biotech Alert: Searches spiking for these stocks today
TipRanks · 05/01 17:55
More
About ABEO
More
Abeona Therapeutics Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing cell and gene therapies for life-threatening diseases. The Company’s lead clinical program is pz-cel, autologous, COL7A1 gene-corrected epidermal sheets, an investigational product in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy cell and gene therapy Good Manufacturing Practice (cGMP) manufacturing facility served as the manufacturing site for pz-cel used in its Phase 3 VIITAL trial and is capable of supporting commercial production of pz-cel upon FDA approval. The Company’s development portfolio also features adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need. The Company’s next-generation AAV capsids are being evaluated to improve tropism profiles for a variety of devastating diseases.
Recently
Symbol
Price
%Change

Webull offers Abeona Therapeutics Inc stock information, including NASDAQ: ABEO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABEO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABEO stock methods without spending real money on the virtual paper trading platform.